Haemonetics Corporation (HAE) Stock Price

HAEStock
$108.32+92.30%52W
Market Cap$4.93B
P/E42.76x
PEG Ratio1.72
Div yield
Beta0.62

HAE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)67.54%
Price vs S&P 500 (4W)28.28%
PEG Ratio1.72
VGM Score62.90
P/E Ratio (Annual)42.76x

HAE Earnings Surprise History

Q2 251.10est. 1.02
Q3 251.27est. 1.11
Q4 251.31est. 1.25
Q1 261.29est. 1.27
Q2 261.14est. 1.08

HAE Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.93
4.07
4.07
4.07

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
HAEHaemonetics Corporation
CCA$108.32
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Haemonetics Corporation

Haemonetics provides medical solutions for blood and plasma collection, processing, and transfusion services across three business segments: plasma, blood center, and hospital. The plasma and hospital segments drive growth due to robust market potential, while the blood center segment faces competitive headwinds. Revenue is generated through sales of disposable collection and processing sets and supporting equipment.